Clinical trials recruiting in Clifton, New Jersey

Phase breakdown

Conditions recruiting in Clifton, New Jersey

Recruiting trials in Clifton, New Jersey

• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
  NCT07690371 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female)
• A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
  NCT06979453 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female)
• Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
  NCT06496256 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male
• Shield Post-Approval Study Protocol
  NCT06880055 · Phase: Not specified · Ages: 45 Years to 81 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Clifton, New Jersey?

5 recruiting trials have at least one study site in Clifton, New Jersey.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.